We are live on ! Find out more
CCM

Copeland Capital Management Portfolio holdings

AUM $4.5B
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
-1.73%
1 Year Est. Return
+18.67%
3 Year Est. Return
+43.33%
5 Year Est. Return
+60.9%
10 Year Est. Return
+320.99%
AUM
$1.95B
AUM Growth
+$448M
Cap. Flow
+$495M
Cap. Flow %
25.32%
Top 10 Hldgs %
17.75%
Holding
208
New
15
Increased
121
Reduced
42
Closed
20

Top Buys

Rank Stock Value
1
CEB
CEB Inc.
CEB
+$24M
2
LHX icon
L3Harris
LHX
+$23.6M
3
BR icon
Broadridge
BR
+$23.1M
4
AVGO icon
Broadcom
AVGO
+$22.5M
5
CWEN.A
Clearway Energy Class A
CWEN.A
+$21M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$21.4M
2
BAX icon
Baxter International
BAX
+$17.7M
3
BRCM
BROADCOM CORP CL-A
BRCM
+$14.3M
4
BLK icon
Blackrock
BLK
+$14M
5
VFC icon
VF Corp
VFC
+$13.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.39%
2 Consumer Discretionary 14.13%
3 Healthcare 13.04%
4 Financials 12.18%
5 Technology 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
126
Novo Nordisk
NVO
$208B
$1.2M 0.06%
43,890
-762,972
-95% -$21.4M
ADP icon
127
Automatic Data Processing
ADP
$106B
$1.1M 0.06%
13,712
+320
+2% +$27.3K
RTX icon
128
RTX Corp
RTX
$290B
$959K 0.05%
13,738
+103
+0.8% +$7.56K
VFC icon
129
VF Corp
VFC
$5.63B
$932K 0.05%
14,196
-203,027
-93% -$13.7M
CNI icon
130
Canadian National Railway
CNI
$76.9B
$862K 0.04%
14,920
+26
+0.2% +$1.63K
BLK icon
131
Blackrock
BLK
$169B
$789K 0.04%
2,280
-38,364
-94% -$14M
EPD icon
132
Enterprise Products Partners
EPD
$82.3B
$759K 0.04%
25,402
-88
-0.3% -$2.88K
AAPL icon
133
Apple
AAPL
$4.54T
$689K 0.04%
21,984
+20
+0.1% +$640
APC
134
DELISTED
Anadarko Petroleum
APC
$624K 0.03%
8,000
XOM icon
135
ExxonMobil
XOM
$644B
$586K 0.03%
7,041
-33
-0.5% -$2.84K
WHG icon
136
Westwood Holdings Group
WHG
$182M
$523K 0.03%
8,785
KDP icon
137
Keurig Dr Pepper
KDP
$42.3B
$435K 0.02%
5,965
ABBV icon
138
AbbVie
ABBV
$443B
$387K 0.02%
5,756
-70
-1% -$4.57K
APA icon
139
APA Corp
APA
$13.2B
$384K 0.02%
6,666
JNJ icon
140
Johnson & Johnson
JNJ
$618B
$358K 0.02%
3,672
-1,250
-25% -$125K
SIAL
141
DELISTED
SIGMA - ALDRICH CORP
SIAL
$310K 0.02%
2,227
-3,600
-62% -$500K
PFE icon
142
Pfizer
PFE
$143B
$266K 0.01%
8,355
+385
+5% +$12.5K
MCD icon
143
McDonald's
MCD
$192B
$247K 0.01%
2,595
-60
-2% -$5.8K
MO icon
144
Altria Group
MO
$114B
$233K 0.01%
4,763
MMM icon
145
3M
MMM
$90.9B
$231K 0.01%
1,794
PM icon
146
Philip Morris
PM
$297B
$220K 0.01%
2,747
-75
-3% -$6.17K
BAX icon
147
Baxter International
BAX
$13.5B
-476,327
Closed -$17.7M
CWEN icon
148
Clearway Energy Class C
CWEN
$4.94B
-428,376
Closed -$10.9M
INFY icon
149
Infosys
INFY
$48.7B
-86,164
Closed -$756K
LNN icon
150
Lindsay Corp
LNN
$1.13B
-73,286
Closed -$5.59M

Similar funds

Copeland Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Copeland Capital Management held 208 positions worth $1.95B, up 30% from $1.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Copeland Capital Management deployed $495M of net new capital in Q2 2015, opening 15 new positions and adding to 121 existing holdings. Its largest new stake was Broadcom: 1,720,870 shares worth $22.9M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $21.4M trimmed.

  • Copeland Capital Management's largest Q2 2015 buy was Broadcom: 1,720,870 shares worth $22.9M.
  • Copeland Capital Management added most to CEB Inc. in Q2 2015, an estimated $24M increase.
  • Copeland Capital Management's biggest Q2 2015 reduction was Novo Nordisk, cutting an estimated $21.4M.
  • Copeland Capital Management fully exited Baxter International in Q2 2015, selling an estimated $17.7M.
  • Copeland Capital Management's ten largest holdings make up 18% of its $1.95B portfolio in Q2 2015.
  • Copeland Capital Management opened 15 new positions and closed 20 in Q2 2015.
  • Copeland Capital Management's portfolio value rose 30% quarter-over-quarter to $1.95B.

Based on Copeland Capital Management's 13F filing for Q2 2015, filed 6 Aug 2015.